Circulating Tumour DNA (ctDNA) as a Prognostic and Predictive Marker in Colorectal Cancer - a Pilot Study
Clinical trial NCT04726800 · UNKNOWN
Trial details
- NCT number
- NCT04726800
- Sponsor
- Anna Martling
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-10-01
- Primary completion
- 2024-12-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.